115 related articles for article (PubMed ID: 11764102)
1. Effect of short-course, high-dose steroid therapy in a child with myelodysplastic syndrome.
Hiçsönmez G; Tunç B; Olcay L; Tuncer MA
Pediatr Hematol Oncol; 2001 Dec; 18(8):525-9. PubMed ID: 11764102
[TBL] [Abstract][Full Text] [Related]
2. The effect of short-course high-dose corticosteroid therapy on peripheral blood CD34+ progenitor cells in children with acute leukemia.
Cetin M; Hiçsönmez G; Tuncer AM; Kansu E; Canpynar H
Exp Hematol; 1996 Aug; 24(10):1191-4. PubMed ID: 8765493
[TBL] [Abstract][Full Text] [Related]
3. High-dose methylprednisolone, low-dose cytosine arabinoside, and mitoxantrone in children with myelodysplastic syndromes.
Hiçsönmez G; Tuncer AM; Sayli T; Güler E; Cetin M; Ozbek N; Mufti GJ
Hematol Pathol; 1995; 9(3-4):185-93. PubMed ID: 8655463
[TBL] [Abstract][Full Text] [Related]
4. Myeloprotective effect of short-course high-dose methylprednisolone treatment before consolidation therapy in children with acute myeloblastic leukemia.
Elmas SA; Cetin M; Tuncer M; Hiçsönmez G
Am J Hematol; 2005 Sep; 80(1):1-5. PubMed ID: 16138333
[TBL] [Abstract][Full Text] [Related]
5. The effect of short-course high-dose methylprednisolone on peripheral blood CD34+ progenitor cells of children with acute leukemia during remission induction therapy.
Tunç B; Oner AF; Hiçsönmez G
Turk J Pediatr; 2002; 44(1):1-4. PubMed ID: 11858371
[TBL] [Abstract][Full Text] [Related]
6. The effect of high-dose methylprednisolone combined chemotherapy on CD34-positive cells in acute lymphoblastic leukemia.
Tuncer AM; Hiçsönmez G; Gümrük F; Albayrak D; Duru F; Güzel E; Sayli T
Hematol Pathol; 1994; 8(4):169-75. PubMed ID: 7532164
[TBL] [Abstract][Full Text] [Related]
7. The role of short course of high-dose methylprednisolone in children with acute myeloblastic leukemia (FAB M2) presented with myeloid tumor.
Hiçsönmez G; Cetin M; Aslan D; Ozyürek E
Pediatr Hematol Oncol; 2003; 20(5):373-9. PubMed ID: 12775535
[TBL] [Abstract][Full Text] [Related]
8. Proliferation of myeloid lineage cells and apoptosis of lymphoblastic leukemic cells induced by short-course high-dose methylprednisolone in patients with acute lymphoblastic leukemia.
Yildiran A; Erduran E; Tekelioğlu Y; Dilber E; Gedik Y
Turk J Pediatr; 2002; 44(2):116-21. PubMed ID: 12026198
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of children with myelodysplastic syndrome: importance of extramedullary disease as a presenting symptom.
Hiçsönmez G; Cetin M; Yenicesu I; Olcay L; Koç A; Aktaş D; Tunçbilek E; Tuncer M
Leuk Lymphoma; 2001 Aug; 42(4):665-74. PubMed ID: 11697496
[TBL] [Abstract][Full Text] [Related]
10. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
Hofmann WK; Heil G; Zander C; Wiebe S; Ottmann OG; Bergmann L; Hoeffken K; Fischer JT; Knuth A; Kolbe K; Schmoll HJ; Langer W; Westerhausen M; Koelbel CB; Hoelzer D; Ganser A
Ann Hematol; 2004 Aug; 83(8):498-503. PubMed ID: 15156346
[TBL] [Abstract][Full Text] [Related]
11. Comparision of the apoptotic effects on lymphoblasts and on increase of myeloid lineage cells of a short-time, high-dose methylprednisolone and the conventional-dose prednisolone treatments in children with acute lymphoblastic leukemia.
Erduran E; Tekelioglu Y; Karakas T; Gedik Y; Mert FM
Pediatr Hematol Oncol; 2006; 23(7):587-98. PubMed ID: 16928654
[TBL] [Abstract][Full Text] [Related]
12. The effect of steroid on myeloid leukemic cells: the potential of short-course high-dose methylprednisolone treatment in inducing differentiation, apoptosis and in stimulating myelopoiesis.
Hiçsönmez G
Leuk Res; 2006 Jan; 30(1):60-8. PubMed ID: 15979702
[TBL] [Abstract][Full Text] [Related]
13. Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia.
Kuendgen A; Knipp S; Fox F; Strupp C; Hildebrandt B; Steidl C; Germing U; Haas R; Gattermann N
Ann Hematol; 2005 Dec; 84 Suppl 1():61-6. PubMed ID: 16270213
[TBL] [Abstract][Full Text] [Related]
14. The effect of short-course high-dose methylprednisolone on peripheral blood lymphocyte subsets in children with acute leukemia during remission induction treatment.
Tunç B; Oner AF; Hiçsönmez G
Leuk Res; 2003 Jan; 27(1):19-21. PubMed ID: 12479848
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N
Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587
[TBL] [Abstract][Full Text] [Related]
16. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
17. The effect of high-dose methylprednisolone on CD34-positive bone marrow cells in the children with acute myeloblastic leukemia.
Tuncer AM; Hiçsönmez G; Gümrük F; Albayrak D; Duru F; Güzel E; Sayli T
Turk J Pediatr; 1995; 37(4):345-9. PubMed ID: 8560602
[TBL] [Abstract][Full Text] [Related]
18. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
Ogasawara T; Yasuyama M; Kawauchi K
Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
[TBL] [Abstract][Full Text] [Related]
19. [Bone marrow cellularity in acute lymphoblastic leukemia of children].
Styczyński J; Kubicka M; Langer B; Wysocki M; Debski R; Wolska E; Polańska M
Wiad Lek; 2000; 53(9-10):507-12. PubMed ID: 11148917
[TBL] [Abstract][Full Text] [Related]
20. A novel approach to treatment in childhood acute myeloblastic leukemia and myelodysplastic syndrome with high-dose methylprednisolone as a differentiation- and apoptosis-inducing agent of myeloid leukemic cells.
Hiçsönmez G
Turk J Haematol; 2010 Mar; 27(1):1-7. PubMed ID: 27265790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
